184
Views
7
CrossRef citations to date
0
Altmetric
PCOS, Insulin like factors and Ovarian Maldescent

Evaluation of the correlation between insulin like factor 3, polycystic ovary syndrome, and ovarian maldescent

&
Pages 481-488 | Received 14 Apr 2017, Accepted 09 Dec 2017, Published online: 19 Dec 2017

References

  • Machiels F , De Maeseneer M , Desprechins B , et al . Unusual location of an ovary: ultrasonographic features and surgical corrections. J Belge Radiol 1998;81:288.
  • Walker RM. Undescended ovaries. Lancet 1935;229:1346.
  • Verkauf BS , Bernhisel MA. Ovarian maldescent. Fertil Steril 1996;65:189.
  • Kives SL , Perlman S , Bond S. Ruptured hemorrhagic cyst in an undescended ovary. J Pediatr Surg 2004;39:e4.
  • Rock JA , Parmley T , Murphey AA , et al . Malposition of the ovary associated with uterine anomalies. Fertil Steril 1986;45:561.
  • Trinidad C , Tardaguila F , Fernandez GC , et al . Ovarian maldescent. Eur Radiol 2004;14:805.
  • Gorgen H , Api M , Delikara N. Undescended fallopian tubes and ovaries: a rare incidental finding during an infertility investigation work up. Acta Obstet Gynecol Scand 2002;81:371.
  • Ombelet W , Grieten M , DeNeubourg P , et al . Undescended ovary and unicornuate uterus: simplified diagnosis by the use of clomiphene citrate stimulation and magnetic resonance imaging (MRI). Hum Reprod 2003;18:858.
  • Siam EM. Successful pregnancy after office microlaparoscopic correction of tubal herneation for a very rare congenital fimbrial-ovarian relationship, a case report. Middle East Fertil Soc J 2011;16:232–5.
  • Bay K , Andersson AM. Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders. Int J Androl 2011;34:97–109.
  • Gambineri A , Patton L , De Iasio R , et al . Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92:2066–73.
  • Nef S , Parada LF. Cryptorchidism in mice mutant for Insl3. Nat Genet 1999;2:295–9.
  • Mehrabian F , Khani B , Kelishadi R , et al . The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol 2011;62:238–42.
  • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod 2004;19:41–7.
  • Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Hum Reprod 2012;27:14–24.
  • Harber TM , Franks S. Genetics of polycystic ovary syndrome. Front Horm Res 2013;40:28–39.
  • Lenarcik A , Bidzińska-Speichert B , Tworowska-Bardzińska U , et al . Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS). Endokrynol Pol 2011;62:129–33.
  • Szydlarska D , Grzesiuk W , Bar-Andziak E. Evolution of polycystic ovary syndromes. Gin Pol Med Project 2010;4:63–8.
  • Bałdys-Waligórska A , Krzentowska-Korek A , Gołkowski F , et al . The predictive value of the IGF-1 level in acromegaly patients treated by surgery and a somatostatin analogue. Endokrynol Pol 2011;62:401–8.
  • Azziz R , Carmina E , Dewailly D , et al . The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456–88.
  • Anand-Ivell RJK , Wohlgemuth J , Haren MT , et al . Peripheral INSL3 concentrations decline with age in a large population of Australian men. Int J Androl 2006;29:618–26.
  • Knudsen HJ , Clausen IH. An extra-uterine pregnancy in an ectopic fallopian tube, a case report. Zentralbl Gynakol 1994;116:544–5.
  • Ivell R , Bathgate RA. Reproductive biology of the relaxin-like factor (RLF/INSL3). Biol Reprod 2002;67:699–705.
  • Szydlarska D , Grzesiuk W , Trybuch A , et al . Insulin-like factor 3 - a new hormone related to polycystic ovary syndrome? Endokrynol Pol 2012;63:356–61.
  • Ivell R , Anand-Ivell R. Biological role and clinical significance of insulin-like peptide 3. Curr Opin Endocrinol Diabetes Obes 2011;18:210–16.
  • Pathirana IN , Kawate N , Büllesbach EE , et al . Insulin-like peptide 3 stimulates testosterone secretion in mouse Leydig cells via cAMP pathway. Regul Pept 2012;178:102–6.
  • Satchell L , Glister C , Bleach E , et al . Ovarian expression of insulin-like peptide 3 (INSL3) and its receptor (RXFP2) during development of bovine antral follicles and corpora lutea and measurement of circulating INSL3 levels during synchronized estrous cycles. Endocrinology 2013;154:1897–906.
  • Pasquali R , Patton L , Pocognoli P , et al . 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92:4208–17.
  • Hanna CB , Yao S , Patta MC , et al . Expression of insulin-like 3 (INSL3) and differential splicing of its receptor in the ovary of rhesus macaques. Reprod Biol Endocrinol 2010;8:150.
  • Ivell R , Anand-Ivell R. The biology of insulin-like factor 3 (INSL3) in human reproduction. Hum Reprod Update 2009;15:463–76.
  • Anand-Ivell R , Dai Y , Ivell R . Neohormones as biomarkers of reproductive health. Fertil Steril 2013;99:1153–60.
  • Gambineri A , Patton L , Prontera O , et al . Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome. J Endocrinol Invest 2011;34:685–91.
  • Glister C , Satchell L , Bathgate RA , et al . A functional link between bone morphogenetic protein and insulin-like peptide 3 signaling in modulating ovarian androgen production. Proc Natl Acad Sci USA 2013;110:E1426–35.
  • Diamanti-Kandarakis E , Papailiou J , Palimeri S. Hyperandrogenemia: npathophysiology and its role in ovulatory dysfunction in PCOS. Pediatr Endocrinol Rev 2006;3:198–204.
  • Ewens KG , Stewart DR , Ankener W , et al . Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab 2010;95:2306–15.
  • Ivell R , Hartung S , Anand-Ivell R. Insulin-like factor 3: where are we now? Ann N Y Acad Sci 2005;1041:486–96.
  • Pelusi C , Fanelli F , Pariali M , et al . Parallel variations of insulin-like peptide 3 (INSL3) and antimullerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern. J Clin Endocrinol Metab 2013;98:E1575–82.
  • Bay K , Cohen AS , Jorgensen FS , et al . Insulin-like factor 3 levels in second-trimester amniotic fluid. J Clin Endocrinol Metab 2008;93:4048–51.
  • Seoud M , Khayyat H , Mufarrij IK. Ectopic pregnancy in an undescended fallopian tube: an unusual presentation. Obstet Gynecol 1987;69:455.
  • McCartney CR , Bellows AB , Gingrich MB , et al . Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome. Am J Physiol Endocrinol Metab 2004;286:E902–8.
  • Van Voorhis BJ , Dokras A , Syrop CH. Bilateral undescended ovaries: association with infertility and treatment with IVF. Fertil Steril 2000;74:1041.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.